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Abstract
Acute HIV-1 infection of CD4 T cells often results in apoptotic death of infected cells, yet it is unclear what evolutionary
advantage this offers to HIV-1. Given the independent observations that acute T cell HIV-1 infection results in (1) NF-kB
activation, (2) caspase 8 dependent apoptosis, and that (3) caspase 8 directly activates NF-kB, we questioned whether these
three events might be interrelated. We first show that HIV-1 infected T cell apoptosis, NF-kB activation, and caspase 8
cleavage by HIV-1 protease are coincident. Next we show that HIV-1 protease not only cleaves procaspase 8, producing
Casp8p41, but also independently stimulates NF-kB activity. Finally, we demonstrate that the HIV protease cleavage of
caspase 8 is necessary for optimal NF-kB activation and that the HIV-1 protease specific cleavage fragment Casp8p41 is
sufficient to stimulate HIV-1 replication through NF-kB dependent HIV-LTR activation both in vitro as well as in cells from
HIV infected donors. Consequently, the molecular events which promote death of HIV-1 infected T cells function dually to
promote HIV-1 replication, thereby favoring the propagation and survival of HIV-1.
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Introduction
From a teleologic standpoint, it has been difficult to reconcile
why a virally infected cell would undergo apoptosis, as it seems
counter-intuitive that virus-initiated death of the host cell could
offer a competitive advantage to that virus. Nonetheless, the
majority of HIV-1 encoded proteins are capable of initiating death
of both HIV-1 infected cells as well as uninfected bystander cells.
The expression of active HIV-1 protease within the cytoplasm of
infected cells, coupled with the degenerate substrate specificity of
HIV-1 protease, allows for host cell proteins to be substrates of
HIV-1 protease [1]. Cleavage of one of these host substrates by
protease, procaspase 8, is a necessary event for death of infected T
cells [2]. Following protease-mediated cleavage, a novel fragment
of procaspase 8, called Casp8p41, is produced, which causes loss of
mitochondrial transmembrane potential, release of cytochrome c,
cleavage and activation of caspase 9 and 3 [2]. Casp8p41 is
specific to HIV-1 protease initiated apoptosis, and is not produced
during apoptosis induced by either death receptor signaling nor
mitochondriotoxic stress [2]. The relevance of Casp8p41 to
infected cell death is suggested by mutational inhibition of HIV-1
protease cleavage of procaspase 8, which inhibits HIV-1 killing of
infected cells [3].
Recently, a non-apoptotic role for procaspase 8 has become
recognized: NF-kB activation in response to antigen receptor, Fc
receptor, or TLR2, 3, 4 ligation requires the presence of
procaspase 8 [4,5]. In response to these stimuli, procaspase 8
complexes with Ikkb, resulting in phosphorylation and proteo-
somal degradation of Ikba, followed by phosphorylation and
nuclear translocation of p65 [4]. More recently, TRAF6 has
been suggested to bind caspase 8, promoting the movement of
this complex into lipid rafts [6]. The interaction of TRAF6 with
caspase 8 is enhanced by caspase 8 processing [6], suggesting
that cleavage of the caspase 8 zymogen enhances the ability of
caspase 8 to activate NF-kB. Also, the structurally related cFLIP
can initiate NF-kB activation via TRAF2 [7], in a manner that is
enhanced by its prior cleavage by caspase 8 [8]. Since HIV-1
protease cleavage of procaspase 8 generates Casp8p41, we
questioned whether Casp8p41 might also drive NF-kB activation
and consequently HIV-LTR driven transcription.
Materials and Methods
Cell Culture
Jurkat (ATCC), J 1.1 (NIH AIDS Reference Reagent Program),
and I 9.2 T-cells as well as primary human CD4+ cells were grown
in RPMI 1640 supplemented with 10% fetal bovine serum and
2 mM Glutamine. Stably transfected I 9.2 cells were grown in
RPMI 1640 with 10% FBS plus 500 ug/ml Geneticin (Invitrogen,
Carlsbad, CA). 293T cells were cultured in DMEM plus 10% FBS
and 2 mM Glutamine. Primary human peripheral blood lympho-
cytes were obtained following informed consent. This protocol was
reviewed and approved by the Mayo Clinic and foundation
institutional review board. HIV infections were performed using
HIV IIIb (National Disease Research Interchange) using a high
MOI of 2.5 mg/ml p24 in the infected supernatant.
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Control of HIV-1 protease expression was accomplished by
cloning the HIV-1 protease gene into the pTet On mammalian
expression vector system (Invitrogen) and inducing expression with
tetracycline as per manufacturer’s recommendations.
The procaspase 8 cDNA was a gift from Dr. Marcus Peter.
The HIV-1 protease resistant caspase 8 construct was made by
mutating the Phenylalanine at amino acid 355 to Arginine and
the Phenylalanine at 356 to Asparagine by site directed
mutagenesis. The Casp8p41 construct was PCR amplified by
designing a reverse primer with a stop codon at amino acid 356
(59-TTAAAACACTTTGGGTTTTC-39) coupled with a
sense primer beginning at the initial ATG (59-ATGGACTT-
CAGCAGAAAT-39) and ligating into the pGEM-T Easy vector
(Promega, Madison, WI) for subsequent cloning. The Casp8p41
DDED construct was PCR amplified using a sense primer
beginning with the Methionine at amino acid 86
(59-ATGGAAAGGGAACTT-39) coupled with the Casp8p41
reverse primer and ligated into pGEM-T Easy (Promega).
Ad o m i n a n tn e g a t i v eI kBa was created to block IKK activation
of NF-kBb yP C Rg e n e r a t e dm u t a g e n esis of Serines 32 and 36
to Alanine [9]. For mammalian expression the constructs
were cloned into either pEGFPo rp c D N A 3( I n v i t r o g e n ) .
All mutations and deletions were confirmed by DNA
sequence analysis and tested for expression prior to experimen-
tal use.
The luciferase reporter constructs HIV-1 LTR Luc, HIV-1
LTR DTAR Luc, and HIV-1 LTR DKB Luc have been
previously described [10]. The TK Renilla plasmid, purchased
from Promega, was used as an internal control in all reporter
plasmid transfections. Transfection efficacies of 30–40% are
routinely achieved in these experiments as assessed by parallel
transfections with expression vectors encoding fluorescent pro-
teins. Results are expressed as luciferase per Renilla expression in
order to normalize for variability between transfection efficiency
and cell viability, between experimental groups, and between
experiments.
Jurkat, I 9.2, and J 1.1 T-cells were transfected with 1 ug
plasmid/10^6 cells using an Electro Square Porator T820 (BTX,
San Diego, CA) at 300 volts for 10 msec. Primary human CD4+
T-cells were harvested from normal or HIV-1 infected donors and
purified using RosetteSep CD4+ Enrichment Cocktail (Stem Cell
Technologies Inc.) and transfected using an Amaxa electroporator
(Amaxa Inc., Koeln, Germany) with programmed routine U14 as
per manufacturer’s recommendations. 293T cells were transfected
using Lipofectamine 2000 reagent (Invitrogen) as per manufac-
turer’s instructions.
Stable Cell Lines
The Jurkat T-derivative cell line, I 9.2, deficient in procaspase
8 protein expression, was stably transfected with expression
vectors encoding for either green fluorescent protein (GFP), or
procaspase 8 wild type conjugated to GFP (GFP-casp 8 WT) or
the HIV-1 protease resistant construct of procaspase 8
conjugated to GFP (GFP-casp 8 RN). After transfection
the cells were placed in media containing 800 ug/ml Geneticin
and cultured for 14 days passing cells every 3 days with
fresh media and Geneticin. The cells were then checked for
GFP expression by fluorescent microscopy and for protein
expression by western blotting. The transfected cells were
maintained in media containing 500 ug/ml Geneticin. For
electroporation experiments the Geneticin was removed
24 hours in advance.
Nuclear Protein Extraction and Electromobility Shift
Assay (EMSA)
293T cells were transfected with empty vector or plasmids
coding for full length procaspase 8 or Casp8p41. After 6 hours at
37uC nuclear proteins were harvested as previously described [11].
5 ug of nuclear protein was allowed to bind to a 32-P labeled,
double stranded, oligonucleotide encompassing the NF-kB
binding site of the HIV-1 LTR (59-ACAAGGGACTTTCC-
GCTGGGGACTTTCCAGGG-39) at room temperature in the
presence or absence of antibodies specific for the NF-kB
transcription factors p50 or p65 (Rel A) (Santa Cruz). The
DNA-nuclear protein complexes were run on a 6% non-
denaturing polyacrylamide gel at a constant voltage of 170volts.
The gel was then dried onto filter paper and exposed to
autoradiography film.
HIV-1 p24 Antigen Assay
The chronically HIV-1 infected Jurkat T-cell clone J 1.1 was
transfected with plasmids encoding for GFP, procaspase 8, or
Casp8p41 with or without dominant negative IkBa (IkBa S 32/36
A). Culture supernatants were harvested 6 hours post transfection
and assayed with the RETROtek HIV-1 p24 ELISA kit
(ZeptoMetrix Corp., Buffalo, NY) for the presence of the HIV-1
antigen p24. Purified human CD4+ lymphocytes from normal and
HIV-1 positive donors were transfected with plasmids encoding for
procaspase 8, or Casp8p41, or GFP to monitor transfection
efficiency. Culture supernatants were collected 18 hours post
transfection and assayed as above.
Flow cytometry for Casp8p41 or p24 was performed on
permealized cells using anti-Casp8p41 monoclonal antibody or
anti-p24 FITC as previously described [3].
Results
HIV-1-induced activation of NF-kB is coincident with HIV-
1-induced cell death
It is established that acute HIV-1 infection of CD4 T cells
results in both NF-kB activation as well as apoptotic cell death
[12]. However, the relative timing of these distinct processes
remains undescribed. First we confirmed the ability of infected
cultures to be efficiently transfected; mock or HIV infected
cultures were transfected with RFP, and subsequently analyzed
for p24 content. Of the RFP positive cells, 40.9% of cells in the
HIV infected cultures were p24 positive, confirming that infected
cells are efficiently transfected (Fig. 1A). Next we transfected
luciferase reporter constructs into mock or HIV infected
cultures, in the presence or absence of an HIV protease
inhibitor, Nelfinavir (Nfv). Since a variety of signals can induce
HIV LTR activity in infected cells, we compared HIV LTR with
and without the TAR region deleted in order to control for the
effect of TAT on NFkB. Both HIV LTR and HIV LTRDTAR
showed an increase in luciferase activity in Day 3 HIV IIIb
infected cells that were diminished by Nfv (Fig. 1B). Luciferasae
activity in the Nfv treated cells was however higher than mock
infected cultures, likely due to the known effect of soluble factors,
such as virion associated gp120 on NFkB mediated HIV
replication [13]. Notably, the magnitude of luciferase induction
in HIV infected cells is similar with respect to fold change in the
HIV LTR compared to HIV LTRDTAR, albeit the absolute
magnitude of induction differed significantly. To control for
potential differences in transfection efficiency as well as
differences in expression between transfected cultures, Renilla
was co-transfected and results expressed as luciferase per Renilla
(Fig. 1B, bottom panels). As with luciferase expression alone,
Casp8p41 Induces HIV
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infection and Nfv treatment between HIV LTR and HIV
LTRDTAR. Therefore, in the ensuing experiments we used
luciferase/Renilla. Next, we performed an acute HIV infection
of Jurkat T cells, and analyzed daily viability and HIV
LTRDTAR activity normalized to Renilla. Mock infected
cultures maintained viability of .95% throughout, and baseline
levels of luc activity. HIV infected cultures reduced viability
beginning on Day 3, and exhibited a reciprocal increase in
luciferase (Fig. 1C). This increase in luciferase and decrease in
viability occurred coincident to increases in Casp8p41 expression
(Fig. 1D) raising the possibility that these events are related.
Further HIV infection in the presence of Nfv which decreased
luciferase activity (Fig. 1B) also reduced Casp8p41 expression
(Fig. 1E).
Expression of HIV-1 protease activates the HIV-1 LTR
Since HIV-1 protease cleavage of procaspase 8 producing
Casp8p41 is a necessary event for death of infected T cells [14],
we questioned whether HIV-1 protease might also be responsible
for the enhanced HIV-1 replication which coincides with
infected cell death. For this, we co-expressed HIV-1 protease
in cells containing an HIV-1 LTR luciferase reporter construct
including the TAR region since TAT is absent in this model. In
such experiments, HIV-1 protease induced 3 to 5 fold greater
HIV-LTR activity than control (data not shown). Moreover, by
using cells deficient in procaspase 8 (I9.2 cells) or the same cells
engineered to express procaspase 8, we assessed the potential
involvement of procaspase 8 in this process. I9.2 cells were stably
transfected with vector control or wild type procaspase 8
(Casp8WT) or procaspase 8 with phenylalanines at positions
355 and 356, mutated to arginine and asparagine, respectively
(Casp8RN), and expression of the transgene confirmed. We have
previously determined that this Casp8RN mutant is resistant to
HIV-1 protease cleavage [3]. When co-transfected with active
HIV-1 protease in the presence of an HIV LTR luciferase
reporter, the I9.2 cells stably expressing wild-type procaspase 8
showed an increase in transcriptional activity (absolute lucifer-
Figure 1. Jurkat T cell upregulate HIV LTR coincident with Casp8p41 expression. (A) Jurkat T cells were acutely infected with HIV IIIb or
mock and three days post infection transfected with RFP. RFP positive cells were gated and p24 content analyzed by intracellular staining with p24
FITC. (B) HIV or mock infected Jurkat T cells were transfected with HIV LTR luciferase or HIV LTRDTAR luciferase reporter constructs with or without
Renilla cotransfection and luciferase measured in the presence or absence of the HIV protease inhibitor Nelfinavir (Nfv). (C) HIV IIIb or mock infected
Jurkat T cells were analyzed daily for viability HIV LTRDTAR luciferase/Renilla activity and (D) Casp8p41 content. (E) Casp8p41 was also measured in
Day 3 HIV infected cells in the presence or absence of Nfv. All results representative of three or more experiments.
doi:10.1371/journal.pone.0002112.g001
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HIV-1 protease in cells containing the cleavage resistant
Casp8RN mutant showed no increase in HIV-LTR transcrip-
tional activity compared to vector control (Figure 2A). The
increase in Luciferase induced by HIV protease in the Casp8WT
cells was inhibited by Nelfinavir (Figure 2B). Therefore, optimal
HIV-1 protease induced HIV LTR activation requires the
presence of procaspase 8 and procaspase 8 must be in a form
which is cleavable by HIV-1 protease.
Casp8p41 activates the HIV-1 LTR in an NF-kB-dependent
manner
Since HIV-1 protease activates the HIV-LTR in cells
containing Casp8WT, but not the cleavage resistant Casp8RN
mutant, the protease cleavage product of procaspase 8 may be
directly involved in HIV-LTR activation. Therefore, we tested
whether casp8p41 would independently activate HIV-LTR, and
compared the effect of casp8p41 to full-length procaspase 8, the
latter of which has been previously reported to stimulate NF-kB
[5]. Full-length procaspase 8 (Casp8FL) or casp8p41 co-expression
with an HIV LTR luciferase reporter plasmid, resulted in an
increase in transcription that was greater in the case of casp8p41
than that of Casp8FL (Fig. 3). The Casp8p41 induced increase in
transcriptional activity was due to NF-kB since the effect was
abrogated in experiments using an HIV-LTR luciferase reporter
construct with the NF-kB sites deleted (Figure 4A). The
involvement of NF-kB was also confirmed by electromobility shift
assay (EMSA), where expression of both full Casp8FL and
Casp8p41 resulted in NF-kB up regulation (Figure 4B). The
specificity of NF-kB response is confirmed by anti-p50 and anti-
p65 antibodies. Comparing the NF-kB response with magnitude
of transgene expression (Figure 4B bottom panel) confirms the
enhanced NF-kB activation of Casp8p41 compared to Casp8FL,
observed in previous experiments using reporter constructs.
Figure 2. HIV protease upregulation of HIV LTR requires caspase 8. (A) The caspase 8 deficient 19.2 cell line was stably transfected with
empty vector control, wild type caspase 8 (Casp8WT) or caspase 8 containing the HIV-1 protease resistant cleavage mutation RN at position 355/356
(Casp8RN), and then transfected with HIV-1 protease along with the HIV-LTR-Luc reporter construct. (B) 19.2 cells were transfected with Casp8WT in
the presence or absence of Nelfinavir (Nfv) and then with HIV protease along with the HIV-LTR-Luc reporter construct. Results of three independent
experiments expressed as fold increase relative to control, normalized to Renilla, +/2 SD.
doi:10.1371/journal.pone.0002112.g002
Figure 3. Casp8p41 upregulates HIV LTR. 293T cells were transfected with empty vector control, HA-Casp8FL or HA-Casp8p41, along with the
HIV-LTR-Luc reporter construct. Transgene expression was confirmed by HA Western Blot. Results expressed as fold increase relative to control,
normalized to Renilla. Results of three independent experiments expressed as fold increase relative to control, normalized to Renilla, +/2 SD.
doi:10.1371/journal.pone.0002112.g003
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Previous studies have determined that the ability of c-FLIP to
drive NF-kB activation is dependent upon the presence of two
tandem DED motifs [8]. Consequently, we assessed whether the
tandem DED motifs present within Casp8p41 were required for
NF-kB activation. Casp8p41 or Casp8p41 containing a truncation
of one DED (Casp8p41DDED) were coexpressed with the HIV
LTR reporter construct. Expression of Casp8p41 induced high
level HIV LTR transcriptional activity that was not present
following expression of Casp8p41DDED (Figure 5).
Casp8p41 induces HIV-1 replication
In order for these effects of casp8p41 to be of relevance to HIV-
1 pathogenesis, the ability of casp8p41 to activate NF-kB should
translate into enhanced viral replication when infected cells
express Casp8p41. We therefore tested whether or not Casp8p41
could increase the production of HIV-1 in an infected cell. To test
this, we chose the Jurkat T cell line J1.1, which is chronically
infected with HIV-1 [15]. In J1.1 cells, we expressed vector
control, Casp8FL, Casp8p41, or Casp8p41 plus a dominant
negative form of IkBa (IkBa 32/36A). The addition of IkBa 32/
36Awas used to confirm that HIV-LTR activation via Casp8p41
occurred via the proposed interaction of caspase 8 with Ikk
resulting in IkBa phosphorylation and degradation. Six hours after
transfection culture supernatants were assayed for the HIV-1
protein, p24, as a marker of HIV-1 replication. The expression of
Casp8FL in J1.1 cells had minimal effect on production of p24.
However, expression of casp8p41 resulted in an increase in p24
present in the culture supernatant, that was blocked by the
dominant negative form of IkBa (Figure 6).
Finally, the effect of Casp8p41 on viral replication was assessed
in primary CD4 T cells from HIV-1 infected or uninfected donors.
Purified primary CD4 T cells were transfected with vector control,
Casp8pFL or Casp8p41, and viral production by P24 antigen
assessed. In 3 of 3 HIV negative donors, no p24 was detected by
any treatment (data not shown). Eight HIV infected donors were
assessed; all had CD4 counts .150, three patients had suppressed
levels of viral replication, and the remaining five had viral loads
between 100 and 73,400. Expression of Casp8FL resulted in an
increase in p24 production relative to control plasmid, yet this
effect was significantly less than the amount of p24 produced in
response to expression of Casp8p41 (Figure 7). The level of p24
production following Casp8p41 expression did not correlate with
plasma viremia, suggesting that level of integrated virus is not
necessarily reflected by in plasma viral load, and that the level of
integrated virus is which dictates the response to Casp8p41.
Discussion
HIV-1 infection of lymphocytes results either in a productive
infection with progeny virion production and death of the infected
cell, or, less commonly, in a latent infection where the cell survives,
yet the virus remains transcriptionally silent. The fact that acute
HIV-1 infection of T cells results in the apoptotic death of those
cells has been difficult to reconcile from a teleologic stand point,
since most viruses, including HIV-1 infection of myeloid cells [16],
Figure 4. Casp8p41 upregulation of HIV LTR is NF-kB
dependent. (A) 293T cells were transfected with empty vector control,
Casp8FL or Casp8p41 along with HIV-LTR-Luc or with HIV-LTR-Luc with
the KB site deleted (HIV-LTR-DKB-Luc) as indicated. Results of three
independent experiments expressed as fold increase relative to control,
normalized to Renilla, +/2 SD. Results expressed as luciferase
expression per Renilla. *p=,0.05 compared to HIV LTR. (B) 293T cells
were transfected with empty vector control HA-Casp8FL or HA-
Casp8p41 and analyzed by EMSA in the presence or absence of anti-
p50 or anti-p65 antibodies. As a control for the antibodies EMSA’s were
performed in cells transfected with p50/p65 in the presence or absence
of anti-p50 or p65 antibodies. The level of Casp8FL and Casp8p41
expression were determined in parallel.
doi:10.1371/journal.pone.0002112.g004
Figure 5. Casp8p41 upregulation of HIV LTR requires DED. 293
T cells were transfected with empty vector control, Casp8p41, or
Casp8p41 with one DED deleted (Casp8p41 DDED), along with HIV-LTR-
Luc, and luciferase measured. Results of three independent experiments
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current data suggest a unifying model wherein HIV-1 replication
and consequent production of HIV-1 protease results in cleavage
of procaspase 8 (which is expressed at high levels in activated T
cells), causing two distinct but related events: mitochondrial
depolarization and apoptosis, as well as NF-kB activation, and
consequent increased production of progeny virions.
Since it has been previously reported that procaspase 8 can
independently drive NF-kB activation, it is likely that procaspase 8
cleavage products should drive NF-kB as well. However, since
most cell types contain procaspase 8, and not all such cells have
high levels of NF-kB activity, it has been difficult to understand the
relevance of full length procaspase 8 activation of NF-kB. Our
data demonstrating that Casp8p41 more efficiently drives NF-kB
and HIV-LTR transcriptional activity than does full length
procaspase 8, suggest first, that caspase cleavage products are a
more physiologic reason for NF-kB activation and second, that in
those experiments where procaspase 8 activated NF-kB, perhaps
the NF-kB activation was due to over expression of full length
procaspase 8 which has previously reported to cause activation of
caspase 8, consequent production of processing intermediates (e.g.
p43). Our data also confirm that the structural components
required for NF-kB activation are the tandem DED motifs and not
the cysteine active site at position 360; furthermore, our data
demonstrate that deletion of one DED is sufficient to abrogate the
NF-kB response. Finally, procaspase 8 binding domains for
TRAF6 at position 395–400 and 416-20, which are missing in
Casp8p41, are not required for NF-kB activation.
Demonstration that Casp8p41 can directly initiate NF-kB
dependent LTR activation, adds to our knowledge of what HIV
specific factors drive HIV replication. First, HIV env binding to
cells drives activation and NF-kB activation. Next, HIV TAT
which is an early gene product potentially activates the LTR vial
interaction with TAR. Later in the viral life cycle HIV Pr is
produced which causes procaspase 8 cleavage resulting in
production of Casp8p41. This in turn contributes to the death
of infected cells [3,14] and as we demonstrate in the current
report, Casp8p41 also activates NF-kB dependent LTR activation.
This effect is independent of TAT or env since reporter constructs
deficient in TAR are increased following HIV infection and since
Casp8p41 expression alone (without other HIV factors present)
drives HIV LTR. Therefore, these data provide a conceptual
model to explain the seeming paradox of why a virus would induce
the death of a host cell; it does so in a manner which favors its own
Figure 6. Casp8p41 upregulates HIV replication. J1.1 cells were transfected with empty vector control, full length caspase 8, Casp8p41, or
Casp8p41 and dominant negative IkBa (IkBa 32/36A). P24 production in culture supernatants were determined. The limit of detection for the p24
assay is ,5 pg/ml. Results of three independent experiments expressed as fold increase relative to control, normalized to Renilla, +/2 SD.
doi:10.1371/journal.pone.0002112.g006
Figure 7. Primary CD4 T cells from HIV infected patients
upregulate HIV replication in response to Casp8p41. Primary
CD4 T cells from eight HIV positive or three HIV negative (data not
shown) donors were transfected with empty vector control, Casp8FL, or
Casp8p41, and p24 antigen production measured in triplicate. The limit
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infect other host cells.
Increased understanding of HIV-1 pathogenesis over the years
has demonstrated the elegant ways that HIV-1 has adapted to use
host metabolism to its advantage (e.g. utilizing LEDGF to facilitate
integration) or ways that HIV-1 has adapted to over come cellular
defenses (e.g. VIF and Apobec). In the current report we
demonstrate that caspase 8 is necessary for optimum HIV-1
protease induced HIV-1 LTR activation (Figure 2) and that
Casp8p41 expression is sufficient to initiate NF-kB dependent
HIV-1 LTR activity (Figures 3 and 4), as well as HIV-1 replication
(Figures 5, 6 and 7). The observation that HIV-1 protease cleavage
of procaspase 8 causes cell death yet has also been adapted by
HIV-1 to promote its own survival by enhancing NF-kB activation
and consequent HIV-1 replication represents a novel case of how
HIV-1 has adapted to overcome a natural host defense strategy.
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